{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T11:46:42Z","timestamp":1791114402216,"version":"4.1.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2012,4,24]],"date-time":"2012-04-24T00:00:00Z","timestamp":1335225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cell Res"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1038\/cr.2012.67","type":"journal-article","created":{"date-parts":[[2012,4,24]],"date-time":"2012-04-24T13:54:53Z","timestamp":1335275693000},"page":"1199-1202","source":"Crossref","is-referenced-by-count":31,"title":["Onconase downregulates microRNA expression through targeting microRNA precursors"],"prefix":"10.1038","volume":"22","author":[{"given":"Meng","family":"Qiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Dong","family":"Zu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Hong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru-Ling","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Cheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mo-Fang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,4,24]]},"reference":[{"key":"BFcr201267_CR1","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1517\/14712598.6.4.391","volume":"6","author":"N Pavlakis","year":"2006","unstructured":"Pavlakis N, Vogelzang NJ . Ranpirnase--an antitumour ribonuclease: its potential role in malignant mesothelioma. Expert Opin Biol Ther 2006; 6:391\u2013399.","journal-title":"Expert Opin Biol Ther"},{"key":"BFcr201267_CR2","doi-asserted-by":"publisher","first-page":"53","DOI":"10.2165\/00063030-200822010-00006","volume":"22","author":"JE Lee","year":"2008","unstructured":"Lee JE, Raines RT . Ribonucleases as novel chemotherapeutics: the ranpirnase example. BioDrugs 2008; 22:53\u201358.","journal-title":"BioDrugs"},{"key":"BFcr201267_CR3","doi-asserted-by":"publisher","first-page":"8711","DOI":"10.1021\/bi000415x","volume":"39","author":"E Notomista","year":"2000","unstructured":"Notomista E, Catanzano F, Graziano G, et al. Onconase: an unusually stable protein. Biochemistry 2000; 39:8711\u20138718.","journal-title":"Biochemistry"},{"key":"BFcr201267_CR4","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1093\/nar\/gkg163","volume":"31","author":"MC Haigis","year":"2003","unstructured":"Haigis MC, Kurten EL, Raines RT . Ribonuclease inhibitor as an intracellular sentry. Nucleic Acids Res 2003; 31:1024\u20131032.","journal-title":"Nucleic Acids Res"},{"key":"BFcr201267_CR5","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/S0079-6603(05)80009-1","volume":"80","author":"KA Dickson","year":"2005","unstructured":"Dickson KA, Haigis MC, Raines RT . Ribonuclease inhibitor: structure and function. Prog Nucleic Acid Res Mol Biol 2005; 80:349\u2013374.","journal-title":"Prog Nucleic Acid Res Mol Biol"},{"key":"BFcr201267_CR6","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1038\/sj.leu.2401100","volume":"12","author":"G Juan","year":"1998","unstructured":"Juan G, Ardelt B, Li X, et al. G1 arrest of U937 cells by onconase is associated with suppression of cyclin D3 expression, induction of p16INK4A, p21WAF1\/CIP1 and p27KIP and decreased pRb phosphorylation. Leukemia 1998; 12:1241\u20131248.","journal-title":"Leukemia"},{"key":"BFcr201267_CR7","first-page":"1983","volume":"60","author":"MS Iordanov","year":"2000","unstructured":"Iordanov MS, Ryabinina OP, Wong J, et al. Molecular determinants of apoptosis induced by the cytotoxic ribonuclease onconase: evidence for cytotoxic mechanisms different from inhibition of protein synthesis. Cancer Res 2000; 60:1983\u20131994.","journal-title":"Cancer Res"},{"key":"BFcr201267_CR8","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1471-2407-10-34","volume":"10","author":"DA Altomare","year":"2010","unstructured":"Altomare DA, Rybak SM, Pei J, et al. Onconase responsive genes in human mesothelioma cells: implications for an RNA damaging therapeutic agent. BMC Cancer 2010; 10:34.","journal-title":"BMC Cancer"},{"key":"BFcr201267_CR9","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1038\/onc.2010.643","volume":"30","author":"CM Goparaju","year":"2011","unstructured":"Goparaju CM, Blasberg JD, Volinia S, et al. Onconase mediated NFK\u03b2 downregulation in malignant pleural mesothelioma. Oncogene 2011; 30:2767\u20132777.","journal-title":"Oncogene"},{"key":"BFcr201267_CR10","first-page":"901","volume":"29","author":"RL Shen","year":"2007","unstructured":"Shen RL, Sun RL, Wang QC, Ou L, Fei J . Growth inhibition effect of onconase on B16 melanoma cells in vivo and in vitro. Chinese J Cell Biol 2007; 29: 901\u2013904.","journal-title":"Chinese J Cell Biol"},{"key":"BFcr201267_CR11","doi-asserted-by":"publisher","first-page":"3119","DOI":"10.1158\/0008-5472.CAN-09-4250","volume":"70","author":"S Jiang","year":"2010","unstructured":"Jiang S, Zhang HW, Lu MH, et al. MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene. Cancer Res 2010; 70:3119\u20133127.","journal-title":"Cancer Res"},{"key":"BFcr201267_CR12","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1182\/blood-2009-05-220814","volume":"114","author":"S Costinean","year":"2009","unstructured":"Costinean S, Sandhu SK, Pedersen IM, et al. Src homology 2 domain-containing inositol-5-phosphatase and CCAAT enhancer-binding protein beta are targeted by miR-155 in B cells of Emicro-MiR-155 transgenic mice. Blood 2009; 114:1374\u20131382.","journal-title":"Blood"},{"key":"BFcr201267_CR13","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/cmi.2009.45","volume":"6","author":"M He","year":"2009","unstructured":"He M, Xu Z, Ding T, Kuang DM, Zheng L . MicroRNA-155 regulates inflammatory cytokine production in tumor-associated macrophages via targeting C\/EBPbeta. Cell Mol Immunol 2009; 6:343\u2013352.","journal-title":"Cell Mol Immunol"},{"key":"BFcr201267_CR14","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1365-2141.2008.07382.x","volume":"143","author":"P Romania","year":"2008","unstructured":"Romania P, Lulli V, Pelosi E, Biffoni M, Peschle C, Marziali G . MicroRNA 155 modulates megakaryopoiesis at progenitor and precursor level by targeting Ets-1 and Meis1 transcription factors. Br J Haematol 2008; 143:570\u2013580.","journal-title":"Br J Haematol"},{"key":"BFcr201267_CR15","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1053\/j.gastro.2007.05.022","volume":"133","author":"F Meng","year":"2007","unstructured":"Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T . MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007; 133:647\u2013658.","journal-title":"Gastroenterology"},{"key":"BFcr201267_CR16","doi-asserted-by":"publisher","first-page":"4373","DOI":"10.1038\/onc.2008.72","volume":"27","author":"Z Lu","year":"2008","unstructured":"Lu Z, Liu M, Stribinskis V, et al. MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene. Oncogene 2008; 27:4373\u20134379.","journal-title":"Oncogene"},{"key":"BFcr201267_CR17","doi-asserted-by":"publisher","first-page":"12201","DOI":"10.1074\/jbc.M504488200","volume":"281","author":"AN Suhasini","year":"2006","unstructured":"Suhasini AN, Sirdeshmukh R . Transfer RNA cleavages by onconase reveal unusual cleavage sites. J Biol Chem 2006; 281:12201\u201312209.","journal-title":"J Biol Chem"},{"key":"BFcr201267_CR18","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/nrc3166","volume":"11","author":"AL Kasinski","year":"2011","unstructured":"Kasinski AL, Slack FJ . Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat Rev Cancer 2011; 11:849\u2013864.","journal-title":"Nat Rev Cancer"}],"container-title":["Cell Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/cr201267.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/cr201267","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/cr201267.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T20:59:34Z","timestamp":1713905974000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cr201267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,24]]},"references-count":18,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["BFcr201267"],"URL":"https:\/\/doi.org\/10.1038\/cr.2012.67","relation":{},"ISSN":["1001-0602","1748-7838"],"issn-type":[{"value":"1001-0602","type":"print"},{"value":"1748-7838","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,24]]}}}